5-[2-(DIETHYLAMINO)ETHYL]-3-PHENYL-1,2,4-OXADIAZOLE CITRATE SALT Cas:1949-20-8

We are 5-[2-(DIETHYLAMINO)ETHYL]-3-PHENYL-1,2,4-OXADIAZOLE CITRATE SALT CAS:1949-20-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


5-[2-(DIETHYLAMINO)ETHYL]-3-PHENYL-1,2,4-OXADIAZOLE CITRATE SALT

Synonyms:
5-[2-(DIETHYLAMINO)ETHYL]-3-PHENYL-1,2,4-OXADIAZOLE CITRATE2,4-oxadiazole,5-(2-(diethylamino)ethyl)-3-phenyl-citrateCITRATO OXOLAMINAoxolamine dihydrogen citrateOxolaminCitrateOXOLAMINE CITRATEOXOLAMINE CITRATE SALT
 
molecular formula: C20H27N3O8
Molecular weight: 437.44400
 
Physical Properties:
Appearance and properties: white or off-white crystalline powder
Density: 1.066g/cm3
Boiling point: 364.8ºC at 760 mmHg
Melting point: 153-154ºC
Flash point: 174.4ºC

 
Specification:
Items of Analysis Standard of Analysis Test Results
Appearance White or almost white powder Conform
Solubility Slightly Soluble in Water and Methanol Conform
Identification IR Conform
Citric acid Content
(on dried basis)
42%-45% 43.8%
Melting Point 140℃-146℃ 142℃
pH 3.5-4.5 3.92
Loss on Drying ≤0.5% 0.11%
Residue on Ignition ≤0.2% 0.05%
Heavy Metals ≤0.002% Conform
Related Substances Benzamidoxime ≤0.1% Not detected
Max Single impurity ≤0.1% 0.06%
Total impurities ≤0.5% 0.11%
Residual Solvents Methanol ≤3000ppm Not detected
n-Hexane ≤290ppm Not detected
Chloroform ≤60ppm 7ppm
Particle Size 90% of particles : less than 15 μm 7.69μm
100% of particles: less than 45 μm 18.12μm
Assay 98%~102% 99.9%
Conclusion Conform to the enterprise standard
 
Application:
Oxolamine Citrate, is a antiinflammatory drug used as a cough suppressant.
 
Package and Storage:
Storage conditions: 2-8ºC
 
 



Market News:“The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. 4-bromo-1,1-dioxothiolan-3-one manufacturer.Considering that small batches present a challenge in proving the robustness of the processing equipment, the Alcami project team, in collaboration with client team members, prepared a failure mode, effects, and criticality analysis (FMECA) of the formulation and process. methyl 7-methyl-2H-benzotriazole-5-carboxylate supplier.Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. 2,2-Propanediylbis(4,1-phenyleneoxy-2,1-ethanediyl) bis(2-methyla crylate) producer.

Related Products
Product Name
4-Fluoroanisole Cas:459-60-9 View Details
erucamide Cas:112-84-5 View Details
docosahexaenoic acid Cas:6217-54-5 View Details
Neratinib Maleate Cas:915942-22-2 manufacturer Doripenem Cas:148016-81-3 manufacturer N-[(4-fluorophenyl)methyl]-1-methylpiperidin-4-amine manufacturer 2-Bromo-4-(trifluoromethyl)phenol manufacturer 2,6-Dichloropyridine manufacturer